X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare IPCA Labs with AANJANEYA LIFECARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs DR. DATSONS LABS - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS DR. DATSONS LABS IPCA LABS/
DR. DATSONS LABS
 
P/E (TTM) x 27.5 -10.9 - View Chart
P/BV x 2.1 0.2 1,297.1% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 IPCA LABS   DR. DATSONS LABS
EQUITY SHARE DATA
    IPCA LABS
Mar-17
DR. DATSONS LABS
Mar-14
IPCA LABS/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs643126 511.9%   
Low Rs50331 1,627.2%   
Sales per share (Unadj.) Rs254.4133.0 191.3%  
Earnings per share (Unadj.) Rs16.10.2 10,599.3%  
Cash flow per share (Unadj.) Rs29.86.6 450.6%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs194.6128.8 151.1%  
Shares outstanding (eoy) m126.2031.66 398.6%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x2.30.6 382.7%   
Avg P/E ratio x35.7516.1 6.9%  
P/CF ratio (eoy) x19.211.8 162.5%  
Price / Book Value ratio x2.90.6 484.7%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m72,3002,477 2,918.4%   
No. of employees `00013.3NA-   
Total wages/salary Rs m6,96056 12,428.2%   
Avg. sales/employee Rs Th2,413.5NM-  
Avg. wages/employee Rs Th523.2NM-  
Avg. net profit/employee Rs Th152.4NM-  
INCOME DATA
Net Sales Rs m32,1064,211 762.5%  
Other income Rs m22679 286.8%   
Total revenues Rs m32,3324,289 753.8%   
Gross profit Rs m4,448569 782.2%  
Depreciation Rs m1,730204 846.1%   
Interest Rs m241430 56.0%   
Profit before tax Rs m2,70313 21,285.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6756 11,068.9%   
Profit after tax Rs m2,0285 42,250.0%  
Gross profit margin %13.913.5 102.6%  
Effective tax rate %25.048.0 52.0%   
Net profit margin %6.30.1 5,540.8%  
BALANCE SHEET DATA
Current assets Rs m17,3406,852 253.1%   
Current liabilities Rs m9,5596,711 142.5%   
Net working cap to sales %24.23.3 723.7%  
Current ratio x1.81.0 177.7%  
Inventory Days Days100161 62.4%  
Debtors Days Days57318 17.9%  
Net fixed assets Rs m20,7793,673 565.7%   
Share capital Rs m252317 79.7%   
"Free" reserves Rs m24,4993,761 651.4%   
Net worth Rs m24,5534,078 602.1%   
Long term debt Rs m3,5171,671 210.5%   
Total assets Rs m39,59512,633 313.4%  
Interest coverage x12.21.0 1,187.5%   
Debt to equity ratio x0.10.4 35.0%  
Sales to assets ratio x0.80.3 243.3%   
Return on assets %5.73.4 166.4%  
Return on equity %8.30.1 7,016.5%  
Return on capital %10.57.7 136.7%  
Exports to sales %48.622.9 212.5%   
Imports to sales %14.214.3 99.6%   
Exports (fob) Rs m15,617964 1,620.1%   
Imports (cif) Rs m4,571602 759.4%   
Fx inflow Rs m15,617964 1,620.1%   
Fx outflow Rs m5,828607 959.9%   
Net fx Rs m9,790357 2,743.0%   
CASH FLOW
From Operations Rs m2,7641,345 205.5%  
From Investments Rs m-1,432-2,256 63.5%  
From Financial Activity Rs m-1,591-1,200 132.6%  
Net Cashflow Rs m-259-2,111 12.3%  

Share Holding

Indian Promoters % 45.9 4.5 1,013.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.4 0.0 -  
FIIs % 25.3 1.4 1,874.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 94.1 18.5%  
Shareholders   36,892 20,807 177.3%  
Pledged promoter(s) holding % 2.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare IPCA LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Aug 21, 2017 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS - ALEMBIC PHARMA COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS